230. Lee S., Barnhill R. L., Dummer R., Dalton J., Wu J., Pappo A., Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms // Sci Rep. ‒ 2015. ‒ T. 5. ‒ C. 11200.
231. Serman N., Vranic S., Glibo M., Serman L., Bukvic Mokos Z. Genetic risk factors in melanoma etiopathogenesis and the role of genetic counseling: A concise review // Bosn J Basic Med Sci. ‒ 2022. ‒ T. 22, № 5. ‒ C. 673-682.
232. Guo J., Qin S., Liang J., Lin T., Si L., Chen X., Chi Z., Cui C., Du N., Fan Y., Gu K., Li F., Li J., Li Y., Liang H., Liu J., Lu M., Lu A., Nan K., Niu X., Pan H., Ren G., Ren X., Shu Y., Song X., Tao M., Wang B., Wei W., Wu D., Wu L., Wu A., Xu X., Zhang J., Zhang X., Zhang Y., Zhu H., written on behalf of Chinese Society of Clinical Oncology Melanoma P. Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition) // Chin Clin Oncol. ‒ 2016. ‒ T. 5, № 4. ‒ C. 57.
233. Stage I melanoma of the skin: the problem of resection margins. W.H.O. Collaborating Centres for Evaluation of Methods of Diagnosis and Treatment of Melanoma // Eur J Cancer. ‒ 1980. ‒ T. 16, № 8. ‒ C. 1079-85.
234. Shelley W., Kersey P., Quirt I., Pater J. Survey of surgical management of malignant melanoma in Canada: optimal margins of excision and lymph-node dissection // Can J Surg. ‒ 1984. ‒ T. 27, № 2. ‒ C. 190-2.
235. Veronesi U., Cascinelli N., Adamus J., Balch C., Bandiera D., Barchuk A., Bufalino R., Craig P., De Marsillac J., Durand J. C., et al. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm // N Engl J Med. ‒ 1988. ‒ T. 318, № 18. ‒ C. 1159-62.
236. Balch C. M., Urist M. M., Karakousis C. P., Smith T. J., Temple W. J., Drzewiecki K., Jewell W. R., Bartolucci A. A., Mihm M. C., Jr., Barnhill R., et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial // Ann Surg. ‒ 1993. ‒ T. 218, № 3. ‒ C. 262-7; discussion 267-9.
237. Ringborg U., Andersson R., Eldh J., Glaumann B., Hafstrom L., Jacobsson S., Jonsson P. E., Johansson H., Krysander L., Lagerlof B. Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group // Cancer. ‒ 1996. ‒ T. 77, № 9. ‒ C. 1809-14.
238. Demidov L. V., Martynova E. V. [Retrospective evaluation of the safe reduction of surgical margins of resected stage-IIA cutaneous melanoma of the trunk and extremities] // Vopr Onkol. ‒ 2002. ‒ T. 48, № 1. ‒ C. 68-73.
239. Khayat D., Rixe O., Martin G., Soubrane C., Banzet M., Bazex J. A., Lauret P., Verola O., Auclerc G., Harper P., Banzet P., French Group of Research on Malignant M. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick) // Cancer. ‒ 2003. ‒ T. 97, № 8. ‒ C. 1941-6.
240. Lens M. B., Newton-Bishop J. A., Dawes M. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick) // Cancer. ‒ 2004. ‒ T. 100, № 2. ‒ C. 433-4; author reply 434.
241. Thomas J. M., Newton-Bishop J., A'Hern R., Coombes G., Timmons M., Evans J., Cook M., Theaker J., Fallowfield M., O'Neill T., Ruka W., Bliss J. M., United Kingdom Melanoma Study G., British Association of Plastic S., Scottish Cancer Therapy N. Excision margins in high-risk malignant melanoma // N Engl J Med. ‒ 2004. ‒ T. 350, № 8. ‒ C. 757-66.
242. Thompson J. F., Scolyer R. A., Uren R. F. Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination // Surg Oncol Clin N Am. ‒ 2006. ‒ T. 15, № 2. ‒ C. 301-18.
243. Gillgren P., Drzewiecki K. T., Niin M., Gullestad H. P., Hellborg H., Mansson-Brahme E., Ingvar C., Ringborg U. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial // Lancet. ‒ 2011. ‒ T. 378, № 9803. ‒ C. 1635-42.
244. Mocellin S., Pasquali S., Nitti D. The impact of surgery on survival of patients with cutaneous melanoma: revisiting the role of primary tumor excision margins // Ann Surg. ‒ 2011. ‒ T. 253, № 2. ‒ C. 238-43.
245. Duffy K. L., Truong A., Bowen G. M., Andtbacka R. H., Hyngstrom J., Bowles T., Grossmann K., Khong H., Hyde M., Florell S. R., Bowen A. R., Wada D., Grossman D. Adequacy of 5-mm surgical excision margins for non-lentiginous melanoma in situ // J Am Acad Dermatol. ‒ 2014. ‒ T. 71, № 4. ‒ C. 835-8.
246. Koskivuo I., Giordano S., Verajankorva E., Vihinen P. One-cm Versus 2-cm Excision Margins for Patients With Intermediate Thickness Melanoma: A Matched-Pair Analysis // Dermatol Surg. ‒ 2015. ‒ T. 41, № 10. ‒ C. 1130-6.
247. Faries M. B., Mozzillo N., Kashani-Sabet M., Thompson J. F., Kelley M. C., DeConti R. C., Lee J. E., Huth J. F., Wagner J., Dalgleish A., Pertschuk D., Nardo C., Stern S., Elashoff R., Gammon G., Morton D. L., Group M.-I. C. T. Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases // Ann Surg Oncol. ‒ 2017. ‒ T. 24, № 13. ‒ C. 3991-4000.
248. Morton D. L., Thompson J. F., Cochran A. J., Mozzillo N., Nieweg O. E., Roses D. F., Hoekstra H. J., Karakousis C. P., Puleo C. A., Coventry B. J., Kashani-Sabet M., Smithers B. M., Paul E., Kraybill W. G., McKinnon J. G., Wang H. J., Elashoff R., Faries M. B., Group M. Final trial report of sentinel-node biopsy versus nodal observation in melanoma // N Engl J Med. ‒ 2014. ‒ T. 370, № 7. ‒ C. 599-609.
249. Cohn-Cedermark G., Rutqvist L. E., Andersson R., Breivald M., Ingvar C., Johansson H., Jonsson P. E., Krysander L., Lindholm C., Ringborg U. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm // Cancer. ‒ 2000. ‒ T. 89, № 7. ‒ C. 1495-501.